Top in hem/onc: Dobbs decision’s impact on cancer care; coffee intake and cancer survival
Delayed care and legal concerns are among clinicians’ primary concerns following the Dobbs v. Jackson Women’s Health Organization decision, which gave states the right to decide the legality of abortion within their borders.
“Think about having to make decisions when a law interrupts a clinician’s ability to provide care for a patient because both the patient and the practitioner are being put at criminal risk for making potential life-saving decisions,” said Jennifer Holter-Chakrabarty, MD, a professor of medicine in the department of hematology and oncology at The University of Oklahoma Health Sciences Center.
Healio spoke with Holter-Chakrabarty and other experts about how the Dobbs decision will affect treatment discussions between cancer care clinicians and patients who are pregnant. It was the top story in hematology/oncology last week.
The second top story was about a study published in European Association of Urology that showed high coffee consumption was associated with longer prostate cancer-specific survival among men with certain metabolism genotypes.
Read these and more top stories in hematology/oncology below:
Treat the mother or save the baby? Unraveling Dobbs decision’s impact on cancer care
The abortion debate in the United States can be viewed through many lenses. Regardless of one’s perspective, one thing is clear: the U.S. Supreme Court decision in June allowing individual states to decide the parameters around abortion services will have an impact on women with cancer — whether they are pregnant before the start of treatment, become pregnant during treatment or desire to have children in the future. Read more.
Coffee intake linked to longer prostate cancer-specific survival for certain men
High coffee consumption appeared associated with increased prostate cancer-specific survival among men with the CYP1A2 AA caffeine metabolism genotype, according to study results published in European Association of Urology. Read more.
Data show ‘critical need’ for universal genetic testing of patients with breast cancer
Universal germline genetic testing benefited patients with breast cancer and their physicians in implementing effective precision treatments and personalized disease management, according to study results published in JAMA Network Open. Read more.
Cost of not having long-term care insurance can outweigh cost of having it, not needing it
Like their patients, physicians often become more concerned about long-term care coverage as they age. For many, it is not until they reach their 50s or 60s that they truly begin to focus on the value this type of policy offers for themselves and their loved ones. Read more.
Diversity director says cancer centers should reflect the communities they serve
Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine has appointed Sophia George, PhD, as the first-ever associate director of diversity, equity and inclusion. Read more.